1997
DOI: 10.1046/j.1537-2995.1997.37597293878.x
|View full text |Cite
|
Sign up to set email alerts
|

A multicenter evaluation of the routine use of a new white cell‐ reduction apheresis system for collection of platelets

Abstract: The protocol selected in the initial phase, now available as a WBC-reduction system, results in platelet concentrates with very low residual WBC levels. This satisfies even the most stringent criteria for WBC reduction in platelets, without the platelet loss typically seen with conventional fiber filtration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
48
1

Year Published

1999
1999
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(53 citation statements)
references
References 18 publications
4
48
1
Order By: Relevance
“…Platelet apheresis was performed using the COBE Spectra LRS or LRS TURBO (Gambro BCT, Lakewood, CO). 11 Residual WBCs in leukocyte-reduced blood products were determined at Gambro BCT by a previously described flow cytometry protocol. 12 Products collected in Denver were shipped overnight with 22°C gel packs from Lakewood to Norfolk for CMV QA-PCR.…”
Section: Blood Productsmentioning
confidence: 99%
“…Platelet apheresis was performed using the COBE Spectra LRS or LRS TURBO (Gambro BCT, Lakewood, CO). 11 Residual WBCs in leukocyte-reduced blood products were determined at Gambro BCT by a previously described flow cytometry protocol. 12 Products collected in Denver were shipped overnight with 22°C gel packs from Lakewood to Norfolk for CMV QA-PCR.…”
Section: Blood Productsmentioning
confidence: 99%
“…Some of the unsatisfactory results of leukodepletion that have been reported even during this decade, may no longer be valid [9, 10], although quality assurance of individual filters remains an issue. Some apheresis procedures such as the Spectra (Cobe BCT, Lakewood, Colo., USA) and Amicus (Baxter Healthcare, Deerfield, Ill., USA), can produce platelet concentrates of sufficient purity to make subsequent filtration unnecessary [11, 12]. …”
Section: The Development Of Blood Component Therapymentioning
confidence: 99%
“…Even in the absence of severe side effects during automated collection procedures [6], the latter has been of growing interest as relatively high rates of citrate reactions have been described recently with new devices [7]. Apart from efficiency and donor comfort, apheresis systems should guarantee consistent product quality, particularly in terms of reliable attainment of the targeted PLT dose and consistent leukoreduction, performed either by filtration or by physical separation, utilizing different cell densities of PLTs and mononuclear cells [8,9]. The white blood cell (WBC) purity obtained by the latter techniques is reported to be more consistent than that obtained upon filtration [10,11].…”
Section: Introductionmentioning
confidence: 99%